Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

NCT07671508 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasms
Tuberculosis (TB)
HEPATITIS C (HCV)

Interventions

DRUG: Naderin
OTHER: Standard Therapy

Sponsor

MIPO Clinic